公司简介

Agendia were founded in 2003 as a spin-off from the Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital in Amsterdam, for the purpose of commercializing molecular diagnostics using DNA microarray technology for cancer diagnosis and drug development

主要成员

Rene Bernards、Peter W. Schineller、Glen Fredenberg、Laura van 't Veer、Bob Brousseau

产品/服务

• 肿瘤基因组

MAMMAPRINT	70-gene breast cancer recurrence assay.
BLUEPRINT	80-gene molecular subtyping assay

融资信息

融资轮次	融资日期	投资方	融资额度
A轮	2004-03	未披露	undisclosed amount
B轮	2005-10	未披露	undisclosed amount
C轮	2006-06	未披露	undisclosed amount
D轮	2007-08	未披露	$34M
E轮	2009-09	未披露	$23M
私募股权	2012-05	Debiopharm Group	$65M

关联公司